Certain medications, including some medications used to treat gastrointestinal disorders, may make it more difficult for some people to absorb B12 from food sources
Our experienced phlebotomists will collect your sample in our comfortable, private facility Results Processing: Our in-house laboratory processes most tests same-day or next-day Results Review: You'll receive your results through our secure patient portal
Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
Individual responses may vary, and pre existing conditions can influence safety
Stabilization of Epithelial and Endothelial Barriers An important aspect of BPC-157 research is its ability to stabilize epithelial and endothelial barrier functions